Reducing Preterm Mortality in Eastern Uganda: the Impact of Introducing Low-cost Bubble CPAP on Neonates <1500 g
Overview
Affiliations
Background: Complications of prematurity are the leading cause of deaths in children under the age of five. The predominant reason for these preterm deaths is respiratory distress syndrome (RDS). In low-income countries (LICs) there are limited treatment options for RDS. Due to their simplicity and affordability, low-cost bubble continuous positive airway pressure (bCPAP) devices have been introduced in neonatal units in LICs to treat RDS. This study is the first observational study from a LIC to compare outcomes of very-low-birth-weight (VLBW) neonates in pre- and post-CPAP periods.
Methods: This was a retrospective study of VLBW neonates (weight < 1500 g) in Mbale Regional Referral Hospital Neonatal Unit (MRRH-NNU), a government hospital in eastern Uganda. It aimed to measure the outcome of VLBW neonates in two distinct study periods: A 14-month period beginning at the opening of MRRH-NNU and covering the period until bCPAP was introduced (pre-bCPAP) and an 18-month period following the introduction of bCPAP (post-bCPAP). After the introduction of bCPAP, it was applied to preterm neonates with RDS when clinically indicated and if a device was available. Clinical features and outcomes of all neonates < 1500 g were compared before and after the introduction of bCPAP.
Results: The admission records of 377 VLBW neonates < 1500 g were obtained. One hundred fifty-eight were admitted in the pre-bCPAP period and 219 in the post-bCPAP period. The mortality rate in the pre- bCPAP period was 39.2% (62/158) compared with 26.5% (58/219, P = 0.012) in the post-bCPAP period. Overall, there was a 44% reduction in mortality (OR 0.56, 95%CI 0.36-0.86, P = 0.01). There were no differences in birthweight, sex, presence of signs of respiratory distress or apnoea between the two groups.
Conclusion: Specialized and resource-appropriate neonatal care, that appropriately addresses the challenges of healthcare provision in LICs, has the potential to reduce neonatal deaths. The use of a low-cost bCPAP to treat RDS in VLBW neonates resulted in a significant improvement in their survival in a neonatal unit in eastern Uganda. Since RDS is one of the leading causes of neonatal mortality, it is possible that this relatively simple and affordable intervention could have a huge impact on global neonatal mortality.
Kakibibi P, Marangu-Boore D, Murila F BMJ Open. 2025; 15(1):e085026.
PMID: 39800403 PMC: 11751814. DOI: 10.1136/bmjopen-2024-085026.
Ahn E, Shayo A, Mselle M, Sechu A, Perlman J J Perinatol. 2024; 45(1):63-67.
PMID: 39406941 DOI: 10.1038/s41372-024-02153-5.
Burgoine K, Ssenkusu J, Nakiyemba A, Okello F, Napyo A, Hagmann C Pilot Feasibility Stud. 2024; 10(1):126.
PMID: 39367449 PMC: 11451038. DOI: 10.1186/s40814-024-01552-x.
Owuor H, Akelo V, Murila F, Onyango D, Kuria M, Rogena E Glob Pediatr Health. 2023; 10:2333794X231212819.
PMID: 38073666 PMC: 10699152. DOI: 10.1177/2333794X231212819.
Wenani D, Burgoine K, Williams S, Musaba M, Gebremichael T, Clarke A BMC Pediatr. 2023; 23(1):223.
PMID: 37147698 PMC: 10163695. DOI: 10.1186/s12887-023-04040-y.